Boehringer Ingelheim Announces Agreement with Ceva Santé Animale for Sale of Certain Merial Assets

GLOBAL - Boehringer Ingelheim, Merial and Ceva Santé Animale (Ceva) announced today that Boehringer Ingelheim and Ceva, a leading global animal health company headquartered in Libourne, France, with vaccine manufacturing presence within the European Union, have entered into a binding put option agreement according to which Ceva will purchase certain assets of Merial’s portfolio in the context of Boehringer Ingelheim’s business swap with Sanofi.
calendar icon 14 October 2016
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.